MedTrace Logo

Children and Parents With ADHD and Related Disorders

NCT01260792 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2600

Last updated 2012-03-26

No results posted yet for this study

Summary

Almost all rating scales for Attention-Deficit/Hyperactivity Disorder (ADHD) are not validated in France. This clearly hampers the development of the diagnosis and the monitoring of patients but also research in this domain. This study is conceived to collect data in the general population of children aged from 4 to 18 years in public schools in the city of Nice.

Children are pseudo-randomly selected from classes of randomly selected schools in the city of Nice (France). Teachers fill out questionnaires using a dedicated secured website, and ask parents to fill out a similar set of questionnaires regarding their child's behaviour at home. Since ADHD has a strong genetic components, parents are also asked to fill out questionnaires regarding their own behaviour at adulthood and in childhood retrospectively.

Additionally, known factors related to ADHD and other disorders as well as other putative factors are tested in the epidemiologic study.

Conditions

  • General Population
  • TDAH
  • Children Aged 5 to 18 Years

Interventions

OTHER

questionnaire

The teachers or the professors complete questionnaires on the child on their behavior in classes

OTHER

Questionnaire

The parents complete a questionnaire on the behavior of their child and on their own behavior

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nice

    lead OTHER

Principal Investigators

  • Hervé CACI, PH · Centre Hospitalier Universitaire de Nice

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-07-31
Completion
2011-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01260792 on ClinicalTrials.gov